Global Bio-chem Technology Group Company Limited (HKG:0809)
Hong Kong · Delayed Price · Currency is HKD 0.3750
-0.0200 (-5.06%)
Sep 11, 2026, 2:40 PM HKT
HKG:0809 Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,096 | 2,279 | 2,001 | 1,374 | 12.71 | 746.55 | |
Revenue Growth | -8.40% | 13.86% | 45.65% | 10709.05% | -98.30% | -12.05% |
Cost of Revenue | 2,058 | 2,082 | 1,782 | 1,330 | 4.82 | 721.29 |
Gross Profit | 38.16 | 196.44 | 218.68 | 43.64 | 7.89 | 25.26 |
Selling, General & Admin | 312.77 | 305.66 | 354.29 | 370.15 | 267.51 | 399.75 |
Other Operating Expenses | 5.55 | - | - | - | 496.39 | 571.34 |
Operating Expenses | 318.32 | 305.66 | 354.29 | 370.15 | 763.89 | 971.09 |
Operating Income | -280.16 | -109.22 | -135.61 | -326.52 | -756.01 | -945.83 |
Interest Expense | -208.77 | -308.11 | -323.4 | -750.35 | -685.18 | -831.69 |
Interest & Investment Income | 0.01 | 0.01 | 0 | 0 | 0.02 | 0.27 |
Earnings From Equity Investments | - | - | - | - | - | -2 |
Currency Exchange Gain (Loss) | -0.57 | 3.01 | 4.52 | - | - | 1.02 |
Other Non Operating Income (Expenses) | -67.88 | -87.16 | -61.74 | -237.56 | 16.22 | 80.19 |
EBT Excluding Unusual Items | -557.37 | -501.47 | -516.23 | -1,314 | -1,425 | -1,698 |
Gain (Loss) on Sale of Investments | - | - | 14.1 | - | - | - |
Gain (Loss) on Sale of Assets | 14.2 | 14.2 | 1,962 | 421.87 | - | - |
Asset Writedown | -68.31 | -68.31 | -714.36 | 7.41 | - | -36.46 |
Other Unusual Items | 715.76 | 711.99 | - | 4,586 | - | 1,325 |
Pretax Income | 104.28 | 156.41 | 745.62 | 3,701 | -1,425 | -409.47 |
Income Tax Expense | 0.11 | 0.11 | -23.98 | -42.08 | -46.79 | 25.92 |
Earnings From Continuing Operations | 104.17 | 156.3 | 769.6 | 3,743 | -1,378 | -435.39 |
Earnings From Discontinued Operations | - | - | - | 481.47 | -141.41 | - |
Net Income to Company | 104.17 | 156.3 | 769.6 | 4,225 | -1,520 | -435.39 |
Minority Interest in Earnings | - | - | - | - | 76.5 | 34.59 |
Net Income | 104.17 | 156.3 | 769.6 | 4,225 | -1,443 | -400.8 |
Net Income to Common | 104.17 | 156.3 | 769.6 | 4,225 | -1,443 | -400.8 |
Net Income Growth | -86.52% | -79.69% | -81.78% | - | - | - |
Shares Outstanding (Basic) | 1,478 | 1,082 | 893 | 891 | 891 | 891 |
Shares Outstanding (Diluted) | 3,205 | 2,809 | 2,620 | 1,408 | 891 | 891 |
Shares Change | 22.34% | 7.21% | 86.05% | 58.07% | - | 4.70% |
EPS (Basic) | 0.07 | 0.14 | 0.86 | 4.74 | -1.62 | -0.45 |
EPS (Diluted) | 0.04 | 0.06 | 0.29 | 2.91 | -1.62 | -0.45 |
EPS Growth | -86.53% | -79.31% | -90.02% | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | - | -28.39 | 76.04 | -94.24 | -94.19 | -501.02 |
Free Cash Flow Per Share | - | -0.01 | 0.03 | -0.07 | -0.11 | -0.56 |
Gross Margin | 1.82% | 8.62% | 10.93% | 3.18% | 62.06% | 3.38% |
Operating Margin | -13.36% | -4.79% | -6.78% | -23.77% | -5947.64% | -126.69% |
Profit Margin | 4.97% | 6.86% | 38.46% | 307.48% | -11352.91% | -53.69% |
Free Cash Flow Margin | - | -1.25% | 3.80% | -6.86% | -740.98% | -67.11% |
EBITDA | -166.11 | -1.89 | 77.05 | -43.5 | -447.63 | -567.57 |
EBITDA Margin | -7.92% | -0.08% | 3.85% | -3.17% | - | -76.03% |
D&A For EBITDA | 114.06 | 107.33 | 212.66 | 283.02 | 308.37 | 378.26 |
EBIT | -280.16 | -109.22 | -135.61 | -326.52 | -756.01 | -945.83 |
EBIT Margin | -13.36% | -4.79% | -6.78% | -23.77% | - | -126.69% |
Effective Tax Rate | 0.10% | 0.07% | - | - | - | - |